Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-10-25 Sale | 2022-10-27 6:00 pm | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 1,588 | $4.4 | $6,987 | 139,354 (Direct) | View |
2022-09-23 Sale | 2022-09-27 7:00 pm | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 1,741 | $3.07 | $5,345 | 140,942 (Direct) | View |
2022-08-24 Sale | 2022-08-26 7:01 pm | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 1,652 | $3.71 | $6,129 | 142,683 (Direct) | View |
2022-07-25 Sale | 2022-07-27 9:02 pm | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 1,686 | $4.33 | $7,300 | 144,335 (Direct) | View |
2022-06-23 Sale | 2022-06-27 7:00 pm | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 1,635 | $4.34 | $7,096 | 146,021 (Direct) | View |
2022-05-20 Sale | 2022-05-24 7:00 pm | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 12,127 | $3.7 | $44,870 | 147,656 (Direct) | View |
2022-04-25 Sale | 2022-04-27 7:00 pm | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 703 | $3.84 | $2,700 | 159,783 (Direct) | View |
2022-03-30 Sale | 2022-04-01 6:00 pm | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 2,486 | $4.84 | $12,032 | 160,486 (Direct) | View |
2022-03-25 Sale | 2022-03-29 6:27 pm | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 7,281 | $5.06 | $36,842 | 165,049 (Direct) | View |
2022-03-18 Sale | 2022-03-22 9:00 pm | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 2,153 | $5.13 | $11,045 | 172,330 (Direct) | View |
2022-03-07 Sale | 2022-03-09 9:45 pm | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 3,091 | $5.52 | $17,062 | 174,483 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-02-22 Other | 2023-02-24 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 1,797 | $8.43 | 134,340 (Direct) | View |
2023-01-24 Other | 2023-01-26 9:01 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 1,838 | $8.56 | 136,178 (Direct) | View |
2022-12-23 Other | 2022-12-28 9:31 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 1,592 | $7.1 | 137,770 (Direct) | View |
2022-11-20 Other | 2022-11-22 6:33 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 1,584 | $5 | 139,354 (Direct) | View |
2022-06-13 Option Award | 2022-06-21 9:11 pm | N/A 2032-06-12 | NeuroPace Inc | NPCE | Kumar Rakhi Director | 18,253 | $0 | 18,253 (Direct) | View |
2022-04-20 Option Award | 2022-04-22 7:29 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 1,000,000 | $0 | 1,000,000 (Direct) | View |
2022-03-30 Tax Withholding | 2022-04-01 6:00 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 2,077 | $4.74 | 160,486 (Direct) | View |
2021-04-21 Option Award | 2021-10-08 6:16 pm | N/A 2031-04-20 | NeuroPace Inc | NPCE | Kumar Rakhi Director | 21,698 | $0 | 21,698 (Direct) | View |
Ownership | 2021-10-01 5:47 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 0 | $0 | 984,440 (Direct) | View |